Skip to main content

The BioCommerce Week Index: Mar 24, 2005

BioCommerce Week’s Index to the
Diversified Molecular Biology Tools Companies
Company
Ticker
Current Price
(March 22, 2005)
Last Price
(
March 15, 2005)
% Change
Agilent
A
22.58
23.26
-2.92
Applied Biosystems
ABI
20.36
20.34
0.10
BD
BDX
58.62
58.85
-0.39
Beckman
BEC
68.90
70.78
-2.66
Bio-Rad
BIO
48.00
47.83
0.36
Bruker
BRKR
3.26
3.95
-17.47
GE
GE
35.50
36.00
-1.39
Harvard Bio
HBIO
4.08
3.95
3.29
Invitrogen
IVGN
71.31
71.40
-0.13
Molecular Devices
MDCC
18.98
18.76
1.17
PerkinElmer
PKI
21.00
21.90
-4.11
Sigma
SIAL
62.07
63.00
-1.48
Stratagene
STGN
8.05
8.00
0.63
Thermo
TMO
25.33
27.45
-7.72
Waters
WAT
46.67
47.85
-2.47
Index Average
34.31
34.89
-1.65

 

Bruker Shares Tumble After 10-K Filing Extension Request

Bruker shares lost 17 percent in the five-day period ending Tuesday and the BioCommerce Week Index finished down for a second consecutive week.

Bruker lost 17 percent of its market capitalization, or $61 million, after announcing last week that it would request an extension of the deadline for filing its 10-K report. The company said it would restate its net loss between $0.07 and $0.09 a share from its previously reported $0.06 a share after finding a "material weakness" in its internal controls at one of its subsidiaries.

Bruker's market cap was $291 million as of market close Tuesday.

Harvard Bio shares gained 3.3 percent on the week, ending a string of five straight weeks of losses, to lead five companies whose shares finished up. Seven companies' shares lost ground as Thermo Electron dropped 7.7 percent, PerkinElmer fell 4 percent, and Agilent dropped 3 percent.

Overall, the Index closed at $34.89 for the five-day period, down 1.65 percent from last week. The Index has closed down for two consecutive weeks and has been down for four of the last six weeks since reaching a high of $36.10 on Feb. 8.

For the week, the Index outperformed the S&P 500 and the Nasdaq, which fell 2 percent, and the Dow Jones, which dropped 2.3 percent. The Amex biotech index was down 0.5 percent while the Amex pharma index fell 1.7 percent.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.